Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow-to-Debt Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥9.12 Million could theoretically repay 0% of its total liabilities (CN¥571.21 Million) in one year. See 300942 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shenzhen Bioeasy Biotechnology Co. Ltd. across 10 annual periods. Also explore Shenzhen Bioeasy Biotechnology Co. Ltd. annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year debt coverage analysis for Shenzhen Bioeasy Biotechnology Co. Ltd.. For market capitalisation and broader financial context, see Shenzhen Bioeasy Biotechnology Co. Ltd. market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥66.87 Million | CN¥616.87 Million | ▲ +85.7% |
| 2024 | 0.06x | CN¥34.26 Million | CN¥586.92 Million | ▲ +179.5% |
| 2023 | -0.07x | CN¥-37.25 Million | CN¥507.61 Million | ▼ -115.3% |
| 2022 | 0.48x | CN¥152.55 Million | CN¥317.75 Million | ▼ -61.3% |
| 2021 | 1.24x | CN¥255.42 Million | CN¥205.94 Million | ▲ +102.0% |
| 2020 | 0.61x | CN¥63.79 Million | CN¥103.90 Million | ▼ -16.6% |
| 2019 | 0.74x | CN¥67.24 Million | CN¥91.35 Million | ▼ -5.7% |
| 2018 | 0.78x | CN¥57.93 Million | CN¥74.22 Million | ▲ +95.8% |
| 2017 | 0.40x | CN¥23.60 Million | CN¥59.19 Million | ▼ -25.5% |
| 2016 | 0.54x | CN¥36.31 Million | CN¥67.83 Million | — |